The International Polycap Study 3 (TIPS-3) is a Randomized Double-blind Placebo-controlled Trial for the Evaluation of a Polycap, Low Dose Aspirin and Vitamin D Supplementation in Primary Prevention

Trial Profile

The International Polycap Study 3 (TIPS-3) is a Randomized Double-blind Placebo-controlled Trial for the Evaluation of a Polycap, Low Dose Aspirin and Vitamin D Supplementation in Primary Prevention

Recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Aspirin (Primary) ; Colecalciferol (Primary) ; Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin (Primary)
  • Indications Cancer; Cardiovascular disorders; Embolism and thrombosis; Fracture; Hyperlipidaemia; Hypertension; Osteoporosis
  • Focus Therapeutic Use
  • Acronyms TIPS-3
  • Most Recent Events

    • 27 Apr 2015 Planned number of patients changed from 5500 to 5000 as reported by ClinicalTrials.gov record.
    • 27 Apr 2015 Planned End Date changed from 1 Jan 2019 to 1 Mar 2020 as reported by ClinicalTrials.gov record.
    • 13 Dec 2012 New source identified and integrated (Clinical Trials Registry - India: CTRI2012-11-003108).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top